Open-Label Extension of Study R727-CL-1003 (NCT01266876) to Evaluate the Long-Term Safety and Efficacy of Alirocumab (REGN727) in Participants With Heterozygous Familial Hypercholesterolemia (HeFH)
Clinical trial NCT01576484 · COMPLETED
Trial details
- NCT number
- NCT01576484
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-28
- Primary completion
- 2016-12-22
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.